Korro Bio, Inc. (KRRO)
7.86
+0.03
(+0.38%)
USD |
NASDAQ |
Dec 11, 16:00
7.60
-0.26
(-3.31%)
After-Hours: 18:33
Korro Bio Profit Margin (Quarterly): -1.66K% for Sept. 30, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Amgen, Inc. | 33.55% |
| Gilead Sciences, Inc. | 39.21% |
| Regeneron Pharmaceuticals, Inc. | 38.89% |
| Vertex Pharmaceuticals, Inc. | 34.76% |
| Nutriband, Inc. | -321.3% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -63.78% |
| Return on Assets | -43.60% |
| Return on Invested Capital | -48.36% |
| Gross Profit Margin (Quarterly) | -10.09% |
| Operating Margin (Quarterly) | -1.76K% |
| Return on Net Operating Assets | -169.4% |